SAR Table 3Additional synthesized and purchased analogs

Compound InformationScreening AssaysProbe Development (AIDs 1806 and 2078)
CompoundSR-NumberStructureCIDSIDMLS IDVendorVendor Catalog IDSTAT3 Primary (AID-862: %INH)STAT1 Primary (AID-920: %INH)STAT3 Confirmation (AID-1265: %INH)NFkB (3X Counterscreen (AID-1308: %INH)STAT1 (3X Counterscreen (AID-1317: %INH)STAT3 Dose Response (AID-1399: IC50, μM)STAT1 Dose Response Counterscreen (AID-1411: IC50, μM)STAT3 IC50 (μM)STAT1 IC50 (μM)Cytotoxicity AssayqPCR Assay
Analog 14SR- 01000410943
Image ml116fu23.jpg
40305457287838NoneInnovapharm Ltd.STT- 00083650These compounds were not in the MLSMR collection.Inactive (>56)Inactive (>56)See below
Analog 15SR- 01000468078
Image ml116fu24.jpg
2233055757287843NoneChemDiv3909-8202Inactive (>56)Inactive (>56)
Analog 16SR- 03000000834
Image ml116fu25.jpg
246109157288036NoneEnamineT0518-5756Inactive (>56)Inactive (>56)
Analog 17SR- 03000000839
Image ml116fu26.jpg
2518130257288041NoneEnamineT5949401Inactive (>56)Inactive (>56)
Analog 18SR- 03000000833
Image ml116fu27.jpg
238396057288035NoneEnamineT0513-7859Inactive (>56)Inactive (>56)
Analog 19SR- 03000000961
Image ml116fu28.jpg
1741558585281103NoneEnamineT5746186Inactive (>18.6 )Inactive (>56)
Analog 20SR- 03000000966
Image ml116fu29.jpg
2462099585281104NoneEnamineT6328260Active (1.84)Inactive (>56)

These compounds were not tested due to lower target potency, compared to probe.

These compounds were not tested due to lower target potency, compared to probe.

From: Modulators of STAT Transcription Factors for the Targeted Therapy of Cancer (STAT3 Inhibitors)

Cover of Probe Reports from the NIH Molecular Libraries Program
Probe Reports from the NIH Molecular Libraries Program [Internet].

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.